158 related articles for article (PubMed ID: 12085566)
1. Chemokines and proteinases in autoimmune diseases and cancer.
Opdenakker G; Van Damme J
Verh K Acad Geneeskd Belg; 2002; 64(2):105-36. PubMed ID: 12085566
[TBL] [Abstract][Full Text] [Related]
2. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
3. On the roles of extracellular matrix remodeling by gelatinase B.
Opdenakker G
Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Dubois B; Opdenakker G; Carton H
Acta Neurol Belg; 1999 Mar; 99(1):53-6. PubMed ID: 10218093
[TBL] [Abstract][Full Text] [Related]
5. Remnant epitopes, autoimmunity and glycosylation.
Opdenakker G; Dillen C; Fiten P; Martens E; Van Aelst I; Van den Steen PE; Nelissen I; Starckx S; Descamps FJ; Hu J; Piccard H; Van Damme J; Wormald MR; Rudd PM; Dwek RA
Biochim Biophys Acta; 2006 Apr; 1760(4):610-5. PubMed ID: 16439062
[TBL] [Abstract][Full Text] [Related]
6. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors.
Gijsbers K; Gouwy M; Struyf S; Wuyts A; Proost P; Opdenakker G; Penninckx F; Ectors N; Geboes K; Van Damme J
Exp Cell Res; 2005 Feb; 303(2):331-42. PubMed ID: 15652347
[TBL] [Abstract][Full Text] [Related]
7. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
[TBL] [Abstract][Full Text] [Related]
8. [Inflammatory cytokines].
Mantovani A
Recenti Prog Med; 2000 Sep; 91(9):422-4. PubMed ID: 11021162
[No Abstract] [Full Text] [Related]
9. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
Descamps FJ; Van den Steen PE; Nelissen I; Van Damme J; Opdenakker G
Adv Exp Med Biol; 2003; 535():69-77. PubMed ID: 14714889
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and their products in rheumatoid arthritis.
Szekanecz Z; Koch AE
Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
12. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.
García-Vicuña R; Gómez-Gaviro MV; Domínguez-Luis MJ; Pec MK; González-Alvaro I; Alvaro-Gracia JM; Díaz-González F
Arthritis Rheum; 2004 Dec; 50(12):3866-77. PubMed ID: 15593223
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
Iwamoto T; Okamoto H; Toyama Y; Momohara S
FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
[TBL] [Abstract][Full Text] [Related]
14. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
Chen X; Oppenheim JJ; Howard OM
Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
[TBL] [Abstract][Full Text] [Related]
15. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
17. The clinical potential of chemokine receptor antagonists.
Ribeiro S; Horuk R
Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
[TBL] [Abstract][Full Text] [Related]
18. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines.
Karin N
Curr Opin Mol Ther; 2004 Feb; 6(1):27-33. PubMed ID: 15011778
[TBL] [Abstract][Full Text] [Related]
20. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
